• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Agfa buys stake in RIS firm

Article

Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for

Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for several years been the exclusive marketer and vendor for Elefante in the Italian market, as part of an integrated RIS/PACS and as a stand-alone RIS. Agfa made the investment to allow greater integration between its Impax and Med2Rad's Elefante, leading eventually to a common IT platform, according to the firm.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.